PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers
NCT07256600 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2025-12-03
Summary
A bioequivalence study comparing DWJ1445 and DWC202506 in healthy adults
Conditions
- Healthy Subjects
Interventions
- DRUG
-
DWJ1445
1 tablet, Orally
- DRUG
-
DWC202506
1 tablet, Orally
Sponsors & Collaborators
-
Daewoong Pharmaceutical Co. LTD.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-11-14
- Primary Completion
- 2025-11-23
- Completion
- 2025-12-02
Countries
- South Korea
Study Locations
More Related Trials
-
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult Volunteers
NCT05954247 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects
NCT02952547 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult Volunteers
NCT05954338 ·Status: UNKNOWN ·Phase: PHASE1
-
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers
NCT06010589 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers
NCT03016520 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects
NCT03016494 ·Status: UNKNOWN ·Phase: PHASE1
-
Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315
NCT06592495 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers
NCT05192395 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II)
NCT04167267 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers
NCT04159961 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component in Healthy Adult Volunteers in Fed Condition.
NCT05823883 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects
NCT05149274 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers
NCT06361277 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult Subjects
NCT07239453 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
To Evaluate the Safety and PK Characteristics in Healthy Volunteers
NCT06355349 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402
NCT02897726 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study of DHP2302R1 and DHP2302R2 in Healthy Adult Volunteers
NCT06318845 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R
NCT06147908 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety Following Administration of DWP16001
NCT05414591 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers
NCT05463497 ·Status: COMPLETED ·Phase: PHASE1
-
Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed State
NCT05098886 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Volunteers
NCT05068193 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine
NCT01094847 ·Status: COMPLETED ·Phase: PHASE1
-
Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fed State
NCT05739916 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects
NCT05023031 ·Status: COMPLETED ·Phase: PHASE1